Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atai Life Sciences N.V. (ATAI)

Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 149.85 (+0.60%)
CMPS : 8.54 (+0.47%)
MNMD : 9.12 (-5.10%)
ATAI : 2.05 (+1.99%)
ABBV : 160.40 (-0.03%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 8.54 (+0.47%)
SEEL : 0.2822 (-2.35%)
ATAI : 2.05 (+1.99%)
MNMD : 9.12 (-5.10%)
NUMI.TO : 0.0700 (-6.67%)
NUMIF : 0.0550 (+0.73%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 8.54 (+0.47%)
SEEL : 0.2822 (-2.35%)
ATAI : 2.05 (+1.99%)
MNMD : 9.12 (-5.10%)
NUMI.TO : 0.0700 (-6.67%)
NUMIF : 0.0550 (+0.73%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CYBN.NE : 0.4950 (-2.94%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 0.3738 (+1.03%)
ATAI : 2.05 (+1.99%)
MNMD : 9.12 (-5.10%)
SEEL : 0.2822 (-2.35%)
CMPS : 8.54 (+0.47%)
3 Big New Catalysts for Psychedelics Stocks in 2024

This could be the year that psychedelics stocks start to fly.

CMPS : 8.54 (+0.47%)
ATAI : 2.05 (+1.99%)
ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT

/CNW/ - This press release is being issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting...

ATAI : 2.05 (+1.99%)
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

ABBV : 160.40 (-0.03%)
ATAI : 2.05 (+1.99%)
CMPS : 8.54 (+0.47%)
MNMD : 9.12 (-5.10%)
JNJ : 149.85 (+0.60%)
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?

Atai's stock is hurting, but its pipeline is still packed with promising programs.

CMPS : 8.54 (+0.47%)
ATAI : 2.05 (+1.99%)
Why Shares of Atai Life Sciences Rose Friday

The company's co-founder and chairman increased his position and explained why.

ATAI : 2.05 (+1.99%)
Why Atai Life Sciences Stock Stormed Higher This Week

The biotech's strong financial position may be attracting bargain buyers right now.

ATAI : 2.05 (+1.99%)

Barchart Exclusives

1 Dividend Aristocrat to Buy for Double-Digit Earnings Growth
Discover why Ecolab's recent earnings beat, along with its robust dividend history, make it a standout choice for investors seeking a blend of growth and stability in 2024. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar